Management of isolated demyelinating episodes by North American neurologists.
Tselis
Alex
A
Chaturvedi
Seemant
S
Borsody
Mark
M
Vaidya
Rohan
R
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002170:Canada; D003711:Demyelinating Diseases / Q000175:diagnosis / Q000188:drug therapy*; D004568:Electrodiagnosis / Q000706:statistics & numerical data; D019538:Health Care Surveys; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy; D009462:Neurology / Q000379:methods* / Q000592:standards; D015835:Ocular Motility Disorders / Q000175:diagnosis / Q000188:drug therapy; D009902:Optic Neuritis / Q000175:diagnosis / Q000188:drug therapy; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D013129:Spinal Puncture / Q000706:statistics & numerical data; D011795:Surveys and Questionnaires; D014481:United States